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Abstract
The antioxidant and anti-inflammatory properties of Citrus flavonoids can play a key role 
in their activity against several degenerative diseases and particularly brain diseases. In 
Brazil promising studies deposited in the patents “pharmaceutical formulation” form was 
obtained from the inclusion of Citrus sinensis L. (orange) essential oil with β-cyclodextrin 
and Citrus limon (lemon) compounds and their applications in therapy of Alzheimer’s 
disease. In this chapter, we report activities of active compounds present in the genus 
Citrus, which include antioxidant, anti-inflammatory, anxiolytic, insecticidal, and anti-
cholinesterase activities. These activities are associated with some neurodegenerative 
diseases such as Alzheimer’s disease (AD). Pharmaceutical formulations containing 
such compounds (for example, inhibitors such as acetylcholinesterase (AChE) of C. limon 
(5,8-dimethoxy-psoralen and 5,7-dimethoxycumarin) and essential oil from C. sinensis oils 
are reported in this chapter. These results indicate that the effects of the essential oil and 
substances of Citrus species are very interesting for further isolation of AChE inhibitors 
that can be used in the formulation of natural products for neurodegenerative diseases.
Keywords: citrus, Citrus sinensis, Citrus limon, acetylcholinesterase, neurodegenerative 
diseases
1. Introduction
Citrus fruits make up the largest sector of the global production of fruits, with more than 100 
million tons produced every season [1]. Citrus is one of the most important genera of Rutaceae 
family because its fruits are estimated primarily as articles of diet [2]. The aromatic oils from 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Citrus are used as flavoring agents in a variety of foods, drinks and confectionery and for fra-
grance applications. There are reports of the Citrus genus with important biological activities, 
namely antioxidant [3, 4], antimicrobial [5], anti-inflammatory [6], insecticidal [7, 8], anxiolytic 
[9], and anticholinesterase [3, 10]. In traditional Chinese medicine, the dried peel of Citrus 
reticulata (mandarin) has been widely used for centuries as a remedy for treating indigestion 
and fighting respiratory tract inflammatory syndromes such as asthma and bronchitis [1]. 
C. aurantium L., commonly known as sour orange bitter, is popularly used as a medicine in 
Brazil and other countries to treat anxiety and insomnia and used as an anticonvulsant, sug-
gesting itcan act as a central nervous system (CNS) depressent [11]. Citrus limon, popularly 
known as lemon, was described possesesing variuos biological activities such as antifungal [12], 
antimicrobial [13], antioxidant [14, 15], antinoceptive [14], and larvicidal [16]. C. limon comprises 
flavonoids, volatile oils, and coumarins; however, their effect on the CNS is not well known [17].
In this chapter, we report activities of active compounds present in the genus Citrus, includ-
ing antioxidant, anti-inflammatory, anxiolytic, insecticidal, and anticholinesterase activities, 
which are associated with some neurodegenerative diseases such as Alzheimer’s disease and 
we report the pharmaceutical formulation of C. limon and Citrus sinensis.
2. Acetylcholinesterase activity (AChE) of Citrus species
Alzheimer’s disease (AD) is a multifactorial disease that affects a significant portion of the 
population and its incidence has grown over the years due to the increasing proportion of 
elderly people in the world population. Factors such as formation of senile plaques and neu-
rofibrillary tangles, reduction of acetylcholine levels (by inhibiting the enzyme acetylcholin-
esterase) and oxidative phenomena are related to the development and/or progression of AD 
[18, 19]. The acetylcholinesterase (AChE), an enzyme inhibitor associated with AD, is widely 
detected by Ellman’s test. According to the principle of the method of Ellman et al. [18], the 
reaction with the thiol has been shown to be sufficiently rapid so as not to be rate limiting in 
the measurement of the enzyme and in the concentrations used does not inhibit the enzymatic 
hydrolysis [18, 19].
Some AChE inhibitors are found naturally in medicinal plants. Reversible cholinesterase 
inhibitors are currently used in clinical trials for treatment of Alzheimer’s disease [4]. The 
treatment is based on the inhibition of AChE, which hydrolyzes acetylcholine, increasing their 
availability to cholinergic transmission [20].
The anticholinesterase activity of extracts from C. limon (lemon) leaves compared to galan-
tamine, a drug widely used in the treatment of AD, and other species used in popular 
medicine in Northeast Brazil are reported in a phytochemical screening [21]. Another study 
described inhibition of a fraction of the ethyl acetate extract from the leaves of C. limon, which 
was isolated from the active fraction named two coumarins: 5,8-dimethoxy-psoralen and 
5,7-dimetoxi-coumarin (Figure 1). In vitro studies indicate IC50 of 5.8 μg mL−1 (95% confidence) 
and in vivo studies with male Swiss mice showed inhibition of 30.09–30.06% for the enzyme 
AChE compared to neostigmine, a drug used in the treatment of AD [11].
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In vitro and in vivo assays with the essential oil of C. sinensis (L.) Osbeck (orange) against 
AChE enzyme indicated that there was a significant decrease in AChE activity in the hip-
pocampal region of mice in in vivo tests. In vitro testing of C. sinensis essential oil showed a 
value inhibition concentration with IC50 = 63 μg mL−1 whereas for the standard (neostigmine) was obtained as IC50 value = 1.87 μg mL−1. For the antioxidant, activity was a significant 20% reduction in the hippocampus of mice treated with 150 mg kg−1on lipid peroxidation, thereby 
reducing oxidative stress and nitrite content, these doses showed a significant reduction in all 
groups, suggesting a neuroprotective effect against brain injury [4].
Studies on the species as Citrus medica L. cv. Diamante (cidra) demonstrated anticholines-
terase activity, which can be explained by the high amount of monoterpenes present in the 
skin of the fruit [10]. According to studies 17 monoterpenoids with p-methane skeleton was 
reported, the AChE inhibitory activity of compounds such as γ-terpinene and terpinen-4-ol 
arrive at 22.6 and 21.4% at 1.2 mM, respectively. Other terpenes such as limonene and linalool 
present in 164 μg mL−1 concentration, inhibition of the 27 and 37%, respectively. The same 
activity is presented to study the species such as Citrus hystrix (Combava), which caused 10% 
inhibition of AChE enzyme and that this action was related to the presence of acyclic and 
monocyclic monoterpenes such as citronellal and β-phellandrene, respectively, present in the 
essential oil extracted from the leaves of this plant [22].
The structural diversity of terpenoids that exert inhibitory activity of AChE is difficult to 
predict the potential structure-activity relationship. But it is known that some features, such 
as the presence of a hydrophobic ligand, may be associated with greater effectiveness in the 
inhibition, since the active site of AChE is known to be susceptible to hydrophobic inter-
actions. The monoterpenes consist of a hydrocarbon skeleton that can be cyclic (α-pinene) 
or acyclic (linalool), a feature that may also influence their AChE inhibitory activity. For a 
bicyclic monoterpene skeleton pinene or carene, the potential of AChE inhibition was associ-





resulted in decreased inhibition of AChE, as well as the presence of an oxygenated functional 
group [20].
Experiments that assess memory evaluate the effects of acute treatment with the essential oil 
of leaves (EOL) from C. sinensis in the acquisition of spatial memory in rats using the para-
digm of the Morris water maze. In Morris assay, the acquisition of memory space is evaluated 
by time the animal takes to locate the platform after having been trained [23].
Figure 1. Inhibitors AChE of C. limon (A) 5,8-dimethoxy-psoralen (B) 5,7-dimethoxycumarin. Molecular structures were 
drawn with ChemDraw13 (Perkin Elmer).
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The composition of EOL of C. sinensis is mainly composed of the class of monoterpenes such 
as limonene (24.14%), citronellol (30.42%), and geranial (31.42%) (Figure 2). The animals were 
previously untreated with doses of EOL of C. sinensis 50, 100, and 200 mg kg−1 and the open 
field test conducted and the Morris water maze task [23].
The acquisition of memory space is evaluated by time the animal takes to locate the platform 
after having been trained. The results of the open field were demonstrated that animals do 
not exhibit motor stimulus when treated with the essential oil of C. sinensis and the results of 
water maze were significantly lower to find the submerged platform than the negative control 
group (p < 0.01) indicating an increased memory capacity in the treated animals, but must be 
reinforced by other memory tests recommended by the literature. These results indicated that 
the effects of the EOL of C. sinensis may involve the cholinergic system and produce a reversal 
of memory impairment, caused by over activity of AChE [4].
Activities of active compounds present in the genus Citrus, which include activities such as 
antioxidant, anti-inflammatory, anxiolytic, insecticidal, and anticholinesterase. These activi-
ties are associated with some neurodegenerative diseases such as Alzheimer’s disease [24].
3. Citrus antioxidants
Oxidative stress produced by free radicals has been implicated in the pathogenesis and pro-
gression of a wide variety of clinical disorders such as cancer, cardiovascular disease, inflam-
mation, epilepsy, diabetes, and Alzheimer’s disease [25]. Oxidative stress is the result of 
natural deficiency of antioxidant defenses, or by increased levels of reactive species derived 
Figure 2. Constituent chemicals of the C. sinensis essential oil. Molecular structures were drawn with ChemDraw13 
(Perkin Elmer).
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), and hydroxyl radicals (OH•) are produced as a result of many biochemical 
reactions and can be considered the main cause of oxidative damage, as protein denaturation 
and lipid peroxidation mutagenesis [10, 27, 28].
The plants of the Citrus genus are rich in compounds that have antioxidant properties [22]. 
Phenolic compounds, particularly flavonoids, have shown an important antioxidant activity, 
which is mainly based on their structural characteristics and other chemical characteristics 
due to the number and position of phenolic hydroxyl groups [29].
Natural antioxidants from fruit juices offer an alternative source of dietary ingredients to pro-
mote healthy life. A recent study on the juice of C. sinensis (L.) Osbeck suggested the influence 
of C-and O-glycosyl flavonoid antioxidants and anticholinesterase properties [24, 30]. From 
the juice, 12 individual components were identified for the first time, namely, four C-glycosyl 
flavones (lucenin-2, vicenin-2, stellarin-2, lucenin-2 40-methyl ether, and scoparin), three fla-
vonol derivatives (quercetin-3-O-(2-rhamnosyl)-rutinoside, quercetin-3-O-hexoside, querce-
tin 3-hydroxy-3-methylglutaryl-glycoside), O-triglycosylflavanone (narirutin 4-O-glucoside), 
and a flavones O-glycosides (chrysoeriol 7-O-neoesperidoside). Moreover, the influence of 
the identified C- and O-glycosyl flavonoids on the antioxidant and acetylcholinesterase activ-
ity of these juices has been evaluated [30].
Thirty-four types of essential oils of Citrus and its components were investigated for their anti-
oxidant activity by 2,2-diphenyl-1-picrylhydrazyl (DPPH). The activity of components compared 
with a standard antioxidant, the trolox showed effects on DPPH scavengers ranging between 
18 and 64%. One possible explanation for the difference in efficiency found in this study may 
be substantial variation in the compounds of the essential oils of citrus. Among the 34 types of 
essential oils, the radical scavenging activity of the lemon (C. ichangensis) species was the largest 
compared to oils Tahiti limon (C. aurantifolia) and eureka lemon (C. limon). Higher antioxidant 
activity of the high amount of terpenes with the exception of limonene and myrcene are reported 
[5]. Generally, the high radical scavenging activity was found when large quantities of terpenes 
include γ-terpinene and terpinolene. In Mexican lemons, Tahiti, eureka, and lisbon, the combined 
percentage of neral and geranial varied from 1.7 to 3.5%. It was also found that the components 
neral and geranial contribute to its effect sequestering these samples. C. sinensis and C. reticulata 
most effective compounds such as γ-terpinene and terpinolene were present in small amounts [5]
The antioxidant effect of α-terpinene, nootkatone, citronellal, citral, γ-terpinene, terpinolene, 
and geraniol substances result showed greater than trolox (p < 0.05). According to calcula-
tions based on the height of the peak of DPPH, γ-terpinene (84.7%), terpinolene (87.4%), and 
geraniol (87.7%) had radical scavenger effect 3.5 times that of trolox. Significant differences 
(p < 0.05) were not found between decanal and geranyl acetate. The antioxidant activity of 
linalool, citronellol, α-pinene, and octanal (18.7–22.4%) was higher than that of α-terpineol, 
octanol, myrcene, decanol, β-pinene, terpen-4-ol, p–cymene, and d-limonene (8.8 to 16.5%) 
[3]. Subsequent studies demonstrated a significant in vitro antioxidant activity of α-terpineol 
against lipid peroxidation inhibition of nitrite ions and hydroxyl radical [5].
The low-density lipoprotein plasma (LDL) plays a significant role in the development of ath-
erosclerosis. The antioxidant activity of the essential oil of three Citrus species (C. natsudaidai, 
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C. hassaku, and C. unshiu) was evaluated and showed promising effects. Studies have shown 
the antioxidative effect to evaluate the effect of citrus essential oil components on human 
LDL in vitro. Among the authentic volatile compounds, tested gamma-terpinene showed the 
strongest antioxidative effect, and inhibited both the Cu2+-induced and AAPH-induced oxida-
tion of LDL. Gamma-terpinene added after 30 min (mid-lag phase) and 60 min (propagation 
phase) of incubation of LDL with Cu2+ inhibited LDL oxidation [31].
4. Citrus anti-inflammatory activity
The inflammation is typically characterized by an increase in tissue permeability and endo-
thelial leukocyte influx of blood into the interstitium, causing edema. Different mediators 
influence each step of the cascade of inflammation and characteristically inflammatory agents 
exhibit therapeutic properties by blocking the action or synthesis of these mediators. While 
inflammation is a normal response to tissue injury, often it is uncontrolled in chronic autoim-
mune diseases such as rheumatoid arthritis and Crohn’s disease, or when related to allergic 
response such as asthma and anaphylactic shock. In these cases, anti-inflammatory com-
pounds are administered therapeutically to control the inflammatory response [32].
Plants rich in certain flavonoids have traditionally been used for its anti-inflammatory prop-
erties, being increasingly reported the isolation of flavonoids, including the Citrus genus with 
anti-inflammatory potential [6]. Citrus flavonoids appear to impact blood and microvascular 
endothelial cells [33].
Studies reported that nobiletin (flavone) is a major component in juice from Citrus depressa, 
it inhibits the invasive activity of human fibrosarcoma HT-1080 cells not only by suppress-
ing the expression of matrix metalloproteinases but also by augmenting metalloproteinases-1 
production [34, 35]. Also, nobiletin prevents tumor-cell invasion due to a decrease of metallo-
proteinase-9 production in the peritoneal dissemination of human gastric carcinoma in severe 
combined immunodeficient mice [36].
Therefore, these results further support the notion that nobiletin is likely to be a candidate for 
characterization as a novel immunomodulatory and anti-inflammatory drug [34].
Citrus peels, the dominant residue, possess a large variety of bioactive compounds; they are 
considered as potential sources of functional components [37]. In traditional herbal medicine 
in Korea, the dried fruit peels of Citrus reticulata have been widely used for centuries as a 
remedy to treat indigestion and to improve inflammatory syndromes of the respiratory tract 
such as bronchitis and asthma [38].
5. Citrus insecticidal
The insecticidal properties have been recognized in the essential oil of many species of the 
Citrus genus and various products containing (+)-limonene, linalool, and crude extract of 
some species of Citrus are already been sold [39].
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Analyses were performed with the potential insecticidal activity by spraying volatile extracts 
from the bark of species two of orange–C. sinensis and C. aurantifolia [7]. Both exhibited, to 
varying degrees, insecticidal activity against mosquito, fly (Musca domestica L.) and cock-
roach. Insecticidal activity was better in the longer period of exposure (60 minutes) compared 
to 30 minutes of spraying. The volatile extracts of C. sinensis showed best potential insecticide 
and cheap. Blattella germanica L) was the species most susceptible to the effects of orange peel 
among the three insects studied. Later studies examined the ability of the insecticide essential 
oil C. sinensis in flies [7].
The observed effect of oil extracted from C. limon on the larvae Culex pipiens (house mosquito) 
and found a positive relationship between the exposure time and the percentage of mortal-
ity of larvae [8]. The extract from the bark of C. aurantium (L.) was evaluated for its toxicity 
against fly of olive (Bactrocera oleae), and fly of mediterranean (Ceratitis capitata). The flies of 
the species B. oleae to extract were more likely than C. capitata in residual contact bioassays. 
Both sexes of B. oleae were equally susceptible in both tests. However, males of the C. capitata 
were more likely than females, which can be best explained by their ability to metabolize 
chemical insecticides [39].
The herbal extracts to inhibit AChE activities are promising for the symptomatic treatment of 
Alzheimer’s disease, a neurodegenerative disease that initially affects memory and thinking 
ability. Research indicates that in the literature, there is a growing search for new inhibitors 
of AChE activity in plant extracts [40]. This search is directed mainly to plants already used 
in traditional medicine for the treatment of insomnia, amnesia, depression, and anxiety, or to 
extend longevity and improve memory and cognitive function. Some plants, such as Centella 
asiatica L. (centelha-asiática) (Umbeliferae) and Ginko biloba L. (ginkgo) (Coniferae), used in 
traditional Indian and Chinese medicine, demonstrated in studies of pharmacological activi-
ties, relevant results in the treatment of cognitive disorders, anticholinesterase, anti-inflam-
matory, and antioxidant actions. In light of these results, these plants have been indicated for 
therapeutic use in the treatment of Alzheimer’s disease [24].
The inhibitory activity of AChE is a significant effect induced by coumarins and particularly 
monoterpenes such as d-limonene. It is also due to the presence of d-limonene from Citrus 
extracts that showed toxic actions in insects, representing a potential alternative to chemical 
insecticides and pharmacological promising to search for inhibitors of the enzyme AChE [41].
6. Terpenes acetylcholinesterase inhibitors as perspective for the 
production of herbal medicines
Pharmacological treatments most commonly employed for Alzheimer’s disease (AD) stands 
out the use of materials whose action increases central cholinergic function, increasing levels 
of acetylcholine in the brain through inhibition of the enzyme acetylcholinesterase (AChE) 
and butyrylcholinesterase (BuChE). These enzymes are responsible for the hydrolysis of ace-
tylcholine to acetate and choline, which prevents its action to the neurotransmitter. The inhi-
bition of the enzyme AChE has been investigated for the treatment of various neurological 
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diseases, and are therefore as the most suitable strategy for the treatment of AD and other 
diseases such as: senile dementia, ataxia, myasthenia gravis, and Parkinson’s disease [42].
Various terpenes present in plant essential oils are reported in the literature showing inhibi-
tory activity against AChE and BuChE for example: ethyl bornila (1) α-pinene (2), β-pinene 
(3) γ-terpinene (4), trans-anethole (5), (+)-limonene (6), (+)-sabinene (7), α-caryophyllene (8), 
and (-)-carvone (9) [24] (Figure 3). In promising studies it was shown that trans-anethole (5) 
compound exhibited the strongest activity against AChE and BuChE, with IC50 values of 134.7 and 209.6 ng mL−1, respectively [43].
Promising studies show that terpenes can have their activity potentiated by complex with cyclo-
dextrins making it a promising source of possible pharmaceutical formulations. The inclusion 
complex obtained between β-cyclodextrin and p-cymene terpene potentiated analgesic and 
anti-inflammatory activities of this monoterpene [44]. The thermal instability, poor solubility in 
water, and the highly volatile compounds are some of the properties of essential oils or terpenes 
that by complexing with cyclodextrins improves its technological applicability [45, 46].
7. Pharmaceutical formulation of citrus
The cyclodextrins (CDs), for example β-cyclodextrins (Figure 4), are composed of complex car-
bohydrates glucose units (α-D-glucopyranose) joined by α-1,4 linkages type, with a structure 
similar to a trunk cone. In 1903 Franz Schardinger identified cyclodextrins, as products result-
ing from the degradation by the action of amylase enzyme. Cyclodextrin starch glycosyl is a 
compounds of CDs that have played an important role in Medicinal Chemistry with regard to 
controlled release technology of drugs, currently represents one of the boundaries of science 
Figure 3. Terpenes AChE and/or BuChE inhibitors (ethyl bornila (1) α-pinene (2), β-pinene (3), γ-terpinene (4), trans-
anethole (5), (+) - limonene (6) and (+) - sabinene (7) α-caryophyllene (8) and (-)- - carvone (9). Molecular structures were 
drawn with ChemDraw13 (Perkin Elmer).
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involving different aspects multidisciplinary knowledge. The delivery systems, often described 
as a “drug delivery systems,” offer numerous advantages when compared to other conven-
tional dosage [47].
In the pharmaceutical industry, the CDs are used mainly to improve stability and bioavail-
ability of the active principle and its organoleptic properties such as taste and smell in phar-
maceutical formulations. The CDs can also be used to mask the unpleasant smell and taste of 
certain drugs, transforming solid liquid compounds, reduce volatility, and avoid undesirable 
mismatches. The increased solubility, dissolution, modification of the pharmacokinetics, and 
controlled release of drugs are other CD applications. The CDs have been used successfully in 
the management and drug delivery by various routes and/or administration sites such as oral, 
vaginal, rectal, nasal, ophthalmic, pulmonary, dermal, and transdermal [47]. Figure 4 shows 
the structure of β-cyclodextrin is widely used as an excipient in pharmaceutical industry at 
low cost and the size of the cavity, which is suitable for encapsulating most substances
In Brazil a pharmaceutical formulation from the essential oil inclusion complex of C. sinensis 
was obtained with β-cyclodextrin and their applications in therapy of disease Alzheimer’s 
(AD). The aim of the present study was to explore the essential oil from leaves of C. sinensis 
(EOLCS) and inclusion complex with the cyclodextrin complexing and their use as a candi-
date drug in the formulation pharmaceuticals for the prevention and/or treatment of AD. 
These properties were determined from experimental models where biological application of 
essential oil (EOLCS) and inclusion complex with cyclodextrin complexing. Inclusion com-
plex with (EOLCS) was proved experimentally by evaluating the inhibitory effect on the activ-
ity of the enzyme AChE in vitro and in vivo (deposit patent number BR 10 2016 0018552).
For the characterization inclusion complex of cyclodextrin and EOLCS was held the infrared 
spectroscopy and differential scanning calorimetry with three proportions, β-CD, and EOLCS, 
denominate of misture physical. It proved the formation of EOLCS complex with β-cyclodextrin 
through the analysis of differential scanning calorimetry, infrared spectra disappearance of the 
Figure 4. Structure of β-cyclodextrin. Seven units of D – (+)-glucopyranose. The CDs have a hydrophobic central cavity 
and a hydrophilic surface. Molecular structures were drawn with ChemDraw13 (Perkin Elmer).
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groups, and thermogram and it can be concluded that the ratio is 6:94 IC greater stability. It was 
shown in preliminary studies that the EOLCS significantly inhibits acetylcholinesterase a total 
of 73% in group 50 mg kg−1, 83% in group 100 mg kg−1, and 76% 200 mg kg−1 and significantly 
improves memory of the animals in promising preclinical studies.
The Citrus sinensis results show a significant pharmacological effect of the compound isolated 
in the inhibition of AChE enzyme activity, and this action of great interest in the development 
of new phytomedicine for the prevention and/or treatment of AD. The results of this effort 
were so promising that we decided to deposit (BR 10 2016 0018552 deposit number) a request 
for a patent, aiming to protect the innovations developed.
The composition of the active fraction in C. limon (L.) Burm leaves is composed of a mixture of 
two coumarins, 5,8-dimethoxy-psoralen and 5,7-dimethoxycoumarin (Figure 1), identified by 1H 
and 13C NMR data analysis, and others experiments. It was also demonstrated that this mixture 
presents qualitative and quantitative AChE inhibition. In vitro studies indicated a CE50 value of 340 μg/mL with 95% of confidence. In vivo studies (10 and 25 mg/kg) revealed inhibition of 30.09 
and 30.06% of AChE activity in relation to neostigmine, respectively. The deposited formulations 
suggest that the isolated fraction C. limon (L.) containing (5,8-dimethoxy-psoralen and 5,7-dime-
thoxycoumarin) can demonstrate inhibitory results of the AChE activity in vitro and in vitro, 
with potential applications in neurodegenerative diseases dependent on the modulation of this 
enzyme, including the Alzheimer’s disease [28]. The sample containing the mixture of isolated 
components showed no toxic properties in rodents, since none of the animals treated with the 
doses of 10 and 25 mg/kg died during the 24-hour observation period. Suggesting that the said 
compound can be used in lower dose and may increase more effectively cholinergic stimulation.
Citrus species are very interesting for further isolation of AChE inhibitors which can be used 
for neurodegenerative diseases for example Alzheimer’s disease application (Figure 5).
Figure 5. Pharmaceutical formulations were obtained from compounds and essential oils of C. limon (e.g., 
5,7-dimethoxycoumarin) and C. sinensis (e.g., geranial). These compounds and essential oils were evaluated in preclinical 
trials on mice by memory tests and enzyme acetylcholinesterase inhibitors and proved to be very promising for potential 
applications in the treatment of neurodegenerative diseases such as Alzheimer’s disease. Molecular structures were 
drawn with ChemDraw13 (Perkin Elmer).
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 Promising preclinical studies were conducted with compounds isolated from some of these 
Brazilian species others namely Platonia insignis (bacurizeiro), Mangifera indica (mango), and 
Kalanchoe brasiliensis (courama branca), for the prevention or progression of Alzheimer’s 
disease [48].
8. Concluding remarks
The results confirm that AChE inhibitors as alternatives for preparation of phytomedicines are 
used in therapeutic treatment of AD, being plants the principal source of these inhibitors. Recent 
studies show that the terpenes may have intensified activities through inclusion complexes with 
cyclodextrins excipient pharmaceutical, making them a promising source for potential pharma-
ceutical formulations.
In general, the formulations reported in this chapter from essential oils or their constitu-
ents is in progress, as they contribute to various activities of plants and open perspectives 
regarding the chemical composition of bioactive metabolites of the studied species and are 
considered promising alternatives to discoveries of new chemical compounds of pharma-
ceutical interest.
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